Tweet
CB also has great anti inflammatory properties which is another contributing factor of hair loss.
-
-
and the initial proof of concept trial showed a 40% increase in density...that kicks the shit out of fin.
CB addresses more issues than fin that's the thing...without sides...game changer for many.Comment
-
Its actually more than 40%. At 1% concentration Cosmo saw 71 grafts/cm2 jump to 109 and at 5% concentration the jump was marginally better from 73 to 111.
The increase in density was roughly 54-55%.
Also, hair diameter went from 0.41mm thickness to 0.88mm.
All without f.cking around with a guys hormones, unlike finasteride garbage.Comment
-
OMG so we were right about Aderans! <SIGH>
If we don't hear from Histogen by September, there is enough reason to be concerned about them too.Comment
-
I don't think so, Gail Naughton said 3 years to release in nonwestern countries at the end of 2012. So that would give them all of 2013 to find an investor and plan the phase IIb trails...which would then be 18 months and the release would be right after that.
And do you really think they won't be able to find a partner to bring this product to the market after the got the results they had? and let's not forget that they haven't even done their dose ranging trial so those results can improve...
They have had better results than any company to date (that we know of), so they should easily get a partner.Comment
-
On a more positive note, just because Ji Gami's cell treatment didn't work doesn't mean new companies will NOT tackle the problem from a new angle!
We live in the age of cell therapies gentlemen, better treatments will come out! It is getting cheaper and cheaper to replicate stem cells, perform genetic testing, screen for trichogenicity and pluripotency, etc!
Future trials will be far more cost-effective than the ones Aderans ran in the last decade. They laid the foundations for the new guys to build on. As we unravel the mysteries of stem cells in the next 5 years, researchers will take advantage of the new possibilities and will try again.
We will have our hairs back to NW1 eventually, just have to be patient and find a current treatment that works for us today until these better treatments come along.Comment
-
I completely agree. Also, this whole ordeal may be tackled from a surgical perspective, if we can get 50% donor regeneration it's only a matter of time before we get that up to 100% and I see that being not far away. Not to mention we have follica who could have a treatment out whenever..they have been silent, but they are obviously on to something big.
That being said I sure wish HSC and CB were out on the market today, I'd get a hairtransplant and hairloss would be a thing of the past for me.Comment
-
Who would have thought that the one that is producing the best results will find it hardest to find an investor!
Oh BTW regarding the Asian release, I have a friend in Singapore that works in the Pharma industry and she was telling me that Singapore still requires a Phase 3 trial but what they allow the companies to do is to use the patients data from Phase 1 & 2 trials as part of Phase 3. So in other words, if you need 1500 trial subjects for your Phase 3 trial, and you have already tested it in 500 subjects in Phase 2 trial, you're allowed to submit your Phase 3 data for the first 1000 of your trial subjects in order to gain product approval.
So pretty much Singapore still requires a Phase 3 but you might gain approval 1-2 years earlier, both because you don't need as many trial subjects to complete the protocol and the fact that their drug approval process is much faster than Western countries.
So I think we should definitely try and clarify this with Gail if she ever comes to see Spencer again.Comment
Comment